FAF
IONS icon

Fjarde Ap-fonden’s Ionis Pharmaceuticals IONS Stock Holding History

Fjarde Ap-fonden’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-57,500
Closed -$2.58M – 571
2021
Q1 		$2.58M Buy
57,500
+3,400
+6% +$190K 0.02% 530
2020
Q4 		$3.06M Buy
54,100
+1,100
+2% +$54.8K 0.03% 502
2020
Q3 		$2.52M Buy
53,000
+5,600
+12% +$311K 0.03% 513
2020
Q2 		$2.79M Sell
47,400
-1,900
-4% -$106K 0.04% 471
2020
Q1 		$2.33M Buy
49,300
+500
+1% +$27.9K 0.04% 451
2019
Q4 		$2.95M Buy
48,800
+16,900
+53% +$1.01M 0.04% 488
2019
Q3 		$1.91M Sell
31,900
-500
-2% -$32.6K 0.02% 539
2019
Q2 		$2.08M Buy
+32,400
New +$2.29M 0.03% 528
2016
Q4 		– Sell
-219
Closed -$8K – 629
2016
Q3 		$8K Sell
219
-35,910
-99% -$1.12M ﹤0.01% 613
2016
Q2 		$841K Sell
36,129
-977
-3% -$31.5K 0.02% 609
2016
Q1 		$1.5M Buy
37,106
+3,241
+10% +$132K 0.03% 553
2015
Q4 		$2.1M Buy
33,865
+1,318
+4% +$71.1K 0.06% 414
2015
Q3 		$1.32M Hold
32,547
– – 0.04% 542
2015
Q2 		$1.87M Sell
32,547
-2,653
-8% -$169K 0.05% 501
2015
Q1 		$2.24M Buy
+35,200
New +$2.39M 0.05% 451

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Fjarde Ap-fonden's IONS Position: Q2 2021 in Review

Fjarde Ap-fonden sold out of Ionis Pharmaceuticals (IONS) in Q2 2021, closing a stake of 57,500 shares — an estimated $2.58M sold.

Fjarde Ap-fonden first reported a position in IONS in Q1 2015 and held it in 15 quarters. The position peaked at $3.06M in Q4 2020. 337 funds tracked by Wall St. Rank hold IONS as of Q2 2021.

  • Fjarde Ap-fonden reported no remaining Ionis Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Fjarde Ap-fonden sold 57,500 Ionis Pharmaceuticals shares in Q2 2021, an estimated $2.58M.
  • Fjarde Ap-fonden first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 15 quarters.
  • Fjarde Ap-fonden's Ionis Pharmaceuticals position peaked at $3.06M in Q4 2020.
  • 337 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2021.

Based on Fjarde Ap-fonden's 13F filing for Q2 2021, filed 12 Aug 2021.